0000000000170347

AUTHOR

W. Zhou

showing 1 related works from this author

IBRUTINIB VS TEMSIROLIMUS: THREE-YEAR FOLLOW-UP OF PATIENTS WITH PREVIOUSLY TREATED MANTLE CELL LYMPHOMA FROM THE PHASE 3, INTERNATIONAL, RANDOMIZED,…

2017

OncologyCancer Researchmedicine.medical_specialtybusiness.industryHematologyGeneral Medicinemedicine.diseaseTemsirolimus03 medical and health scienceschemistry.chemical_compound0302 clinical medicineOncologychemistry030220 oncology & carcinogenesisInternal medicineIbrutinibMedicineMantle cell lymphomaOpen labelbusinessPreviously treated030215 immunologymedicine.drugHematological Oncology
researchProduct